Using a dorsal window chamber, tumours were generated via subcutaneous implantation of HT1080 cells that transgenically express a fluorescently tagged DNA damage response protein, 53BP1-mApple, which localizes to the nucleus39 (Supplementary Fig. 8a). The gene discussed is TP53BP1; the disease is neoplasm.